NYSE:AGL

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$14.4b

Last Updated

2021/07/28 02:55 UTC

Data Sources

Company Financials +

Executive Summary

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. More Details


Snowflake Analysis

Exceptional growth potential with worrying balance sheet.


Similar Companies

Share Price & News

How has agilon health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AGL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: Insufficient data to determine AGL's volatility change over the past year.


Market Performance


7 Day Return

6.2%

AGL

0.2%

US Healthcare

0.9%

US Market


1 Year Return

n/a

AGL

35.6%

US Healthcare

37.8%

US Market

Return vs Industry: Insufficient data to determine how AGL performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how AGL performed against the US Market.


Shareholder returns

AGLIndustryMarket
7 Day6.2%0.2%0.9%
30 Day-6.2%-0.3%0.3%
90 Day15.3%2.9%2.1%
1 Yearn/a37.2%35.6%40.0%37.8%
3 Yearn/a54.7%48.4%63.8%53.5%
5 Yearn/a102.6%87.3%124.6%99.7%

Long-Term Price Volatility Vs. Market

How volatile is agilon health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is agilon health undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Below Fair Value: AGL ($36.95) is trading above our estimate of fair value ($34.56)

Significantly Below Fair Value: AGL is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AGL is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: AGL is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AGL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AGL has negative assets, so we can't compare its PB Ratio to the US Healthcare industry average.


Future Growth

How is agilon health forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

73.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AGL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: AGL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AGL's is expected to become profitable in the next 3 years.

Revenue vs Market: AGL's revenue (27.5% per year) is forecast to grow faster than the US market (9.2% per year).

High Growth Revenue: AGL's revenue (27.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AGL's Return on Equity is forecast to be very high in 3 years time (114%).


Past Performance

How has agilon health performed over the past 5 years?

28.1%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: AGL is currently unprofitable.

Growing Profit Margin: AGL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if AGL's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare AGL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AGL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (58.4%).


Return on Equity

High ROE: AGL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is agilon health's financial position?


Financial Position Analysis

Short Term Liabilities: AGL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: AGL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: AGL has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: AGL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AGL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AGL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is agilon health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AGL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AGL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AGL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AGL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AGL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average management tenure


CEO

Steve Sell (55 yo)

1.08yrs

Tenure

Mr. Steven Jackson Sell, also known as Steve, is President and Chief Executive Officer at Agilon Health, Inc. since June 1, 2020 and also serves as its Director since June 2020. Mr. Sell also serves as an ...


Leadership Team

Experienced Management: AGL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

Experienced Board: AGL's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: AGL only recently listed within the past 12 months.


Top Shareholders

Company Information

agilon health, inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: agilon health, inc.
  • Ticker: AGL
  • Exchange: NYSE
  • Founded: 2016
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$14.441b
  • Shares outstanding: 390.83m
  • Website: https://agilonhealth.com

Number of Employees


Location

  • agilon health, inc.
  • 1 World Trade Center
  • Suite 2000
  • Long Beach
  • California
  • 90831
  • United States

Listings


Biography

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed i...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/28 02:55
End of Day Share Price2021/07/27 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.